Is peritoneal dialysis the preferred modality in the diabetic patient?
There has been much debate recently whether peritoneal dialysis is an acceptable modality of renal replacement therapy in the diabetic patient. The authors review the recent continuous ambulatory peritoneal dialysis (CAPD) mortality literature and suggest that mortality can be improved by increasing the quantity of peritoneal dialysis delivered. The major disadvantages and advantages of CAPD are reviewed and presented. Peritoneal dialysis remains a viable modality of renal replacement therapy in the appropriate diabetic patient provided an adequate dose of dialysis is maintained.
Kraus
M A
MA
Indiana University Medical Center, Indianapolis, USA.
Hamburger
R J
RJ
D000328:Adult; D000368:Aged; D003928:Diabetic Nephropathies / Q000401:mortality* / Q000628:therapy; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000401:mortality* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000401:mortality*; D015996:Survival Rate; D016896:Treatment Outcome